The Journal of Transcatheter Interventions (J Transcat Intervent), e-ISSN 2595-4350, is a publication of the Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista(SBHCI). The decisions of the journal editors and members of the boards are made independently of SBHCI or publishing partners. The editor-in-chief is responsible for selection and management of the National and International Editorial Boards.
The journal publishes articles related to percutaneous intervention in heart diseases (coronary and non-coronary), peripheral and cerebrovascular diseases. Also considered for publication are manuscripts addressing pharmacological, pathophysiological, and diagnostic aspects linked to percutaneous intervention in cardiovascular diseases. The journal does not intend to publish articles on heart electrophysiology or cardiac surgery.
Original Articles, Study Designs, Review Articles, Case Reports, Images in Cardiovascular Intervention, Editorials, and Letters to the Editor, submitted in Portuguese, Spanish and English, and available in electronic format, are accepted for publication.
The authors are fully responsible for the concepts described in the manuscripts submitted to publication, which do not reflect the opinion of the journal editors.
The Journal of Transcatheter Interventionsis an open access journal and does not charge any fees for submission, review, translation, and publication of articles. All processes are conducted electronically and may be accessed at www.jotci.org.
The content of the Journal of Transcatheter Interventionsis under license given by Creative Commons− Attribution 4.0 International (CC BY 4.0; https://creativecommons.org/licenses/by/4.0/deed.pt), which allows copy, use, and distribution of the contribution by any means, including for commercial purposes, as long as the original manuscript is duly cited.
ETHICS AND GUIDELINES FOR SPECIFIC STUDIES
All research projects directly or indirectly involving human beings should be submitted for appraisal of the in Human Research Ethics Beings Committee(CEP, acronym in Portuguese). The authors must send the project via Plataforma Brasil, by means of the link http://aplicacao.saude.gov.br/plataformabrasil/login.jsf. It is mandatory to indicate on the manuscript the number of the Certificate of Presentation for Ethical Consideration (CAAE, acronym in Portuguese) of Plataforma Brasil. (www.saude.gov.br/plataformabrasil).
All efforts should be made to protect privacy and anonymity of patients. The information regarding identification, including photos, should not be included in the manuscript.
The policy for registration of clinical studies of the International Committee of Medical Journal Editors(ICMJE) requires the record of all prospective clinical trials. The manuscripts will only be accepted for publication if they have received an identification number from one of Clinical Trial Registries validated by the World Health Organization (WHO) and by ICMJE; their addresses are available at the website of the latter (http://www.icmje.org/), such as, for example, www.ensaiosclinicos.gov.br or www.clinicaltrials.gov. The identification number should be included at the end of the abstract.
In the experimental projects involving animals, the rules to be complied with are established by the Guide for the Care and Use of Laboratory Animals(Institute of Laboratory Animal Resources, National Academy of Sciences, Washington, DC, United States), of 1996, and by the Ethical Principles in Animal Experimentation (Colégio Brasileiro de Experimentação Animal– COBEA, available at www.cobea.org.br), of 1991.
The manuscripts should be in conformity with the following guidelines for generation of reports:
- CONSORT (Consolidated Standards of Reporting Trials).
- STARD (Standards for Reporting Diagnostic Accuracy Studies).
- PRISMA (Systematic Reviews and Meta-Analyses).
- STROBE (Reporting of Observational Studies in Epidemiology).
ConfliCts OF interesT
When electronically submitting their articles, all authors should declare their Conflicts of Interest. These encompass possible involvement with the device or pharmaceutical industries in the previous two years, related to percutaneous intervention in cardiac, peripheral, and cerebrovascular diseases.
All sources of funding of the project should be cited. Other relations with the industry, such as paid consultancy or lecturers, sponsorships for scientific events, other sponsorships (receiving drugs, equipment, or administrative support), fees and equity stakes, should be explained to the editor.
If there are no conflicts of interest, this condition must also be declared.
Plagiarism and misconduct
Regarding the policy of protection and intellectual property, the Journal of Transcatheter Interventionsadopts specific procedures to combat the practice of plagiarism in publications. If a reviewer or editor suspects there was plagiarism, the article is submitted to a review using the iThenticate software. Next, the case is taken up for debate with the associate editors, for consensus decision making.
Other decisions relative to ethics, misconduct, and integrity of scientific research are based on the orientations of the Code of Conduct for Journal Editors(COPE), available at http://publicationethics.org/files/Code_of_conduct_for_journal_ editors_Mar11.pdf, and from the World Association of Medical Editors(WAME), available at http://www.wame.org
CriTERIA FOR AUTHORSHIP
The Journal adopts the authorship criteria of ICMJE (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html).
Authorship of the manuscripts should be based on: (1) conception, planning, analysis or data interpretation; (2) wording of the article or its critical intellectual review; (3) responsibility for the final approval of the publication; (4) concordance so that one of the authors is responsible for all stages of the work, assuring that issues related to accuracy or integrity of any part of the article are duly investigated and settled.
Participations that do not satisfy these criteria should be listed in the Acknowledgements item.
The inclusion or exclusion of names of authors during the review process may be made only after approval of the editor and with the consent signature of all authors. Such changes are not allowed after approval of the article.
These may be made to people who collaborated with the project intellectually, provided they do not satisfy the requirements for participating as authors of the manuscript, and have no links with the organizations that may have offered financial and/or logistic support. The individuals mentioned should send a letter authorizing the inclusion of their names in that section (due to possible implication in the endorsement of data and conclusions). Written consent is not necessary if the acknowledgments are to be made to members of the work team. They should have, at most, 50 words.
EVALUATION OF manuscriPts
Initially, the editorial secretary checks if the general rules for preparation of articles were followed, as well as if the content was entirely submitted (figures with adequate quality, tables, submission letter, declarations of conflict of interest, of source of financing, CAAE number, etc.). Articles submitted not complying with these instructions are immediately sent back to the authors, with a scheduled date for their return.
The manuscripts are analyzed by the editor-in-chief and coeditor, who decide about sending or not to peer review.The review process by peers is coordinated by one of the associate editors. The manuscripts are always evaluated by at least two reviewers. In case of discrepancy between them, a new opinion may be requested for an editorial decision. After peer review, the manuscripts are forwarded to the authors for the corrections requested, and returned to the reviewer, who analyzes the modifications, and can request new changes or issue their recommendation for publication or rejection.
Based on the recommendations of the peers and associate editors, the article goes back to the editor-in-chief or coeditor, who makes the final decision as to new technical corrections, publication, or rejection, and this is communicated to the corresponding author.
After this phase, all approved articles are included in the editorial process flow, which consists of grammatical review, technical review as to suitability of scientific writing, translation by a specialist in English language, and layout. After layout, the author receives a PDF file for review and approval of the content. The approval period of the PDF by the author is 48 hours, and once this time is up, the content is considered approved, even if the author did not inform of their approval.
The manuscripts should be submitted online,following the instructions displayed at journal website.The texts and tables should be edited in Word, presented in Arial size 12, with double spacing between lines. The number of words should not exceed that recommended for each category of article.
The Journal of Transcatheter Interventionsadopts the rules for publication established in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication,available at www.icmje.org.
The Journal of Transcatheter Interventionsmaintains two social media platforms: the @JOTCI page at Twitter and another at Facebook. The content is created by the social media editor of the journal, who is a member of the editorial board, in order to guarantee scientific precision. The Journal of Transcatheter Interventionsteam publishes the content and manages the platforms.